A randomised controlled blinded trial to investigate the effect of hyoscine butylbromide during colonoscopy on rates of polyp detection.

Phase 4

Completed

• Conditions: Colonic polyposis; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Cancer - Bowel - Back passage (rectum) or large bowel (colon)

• Registration Number: ACTRN12608000600347
• Lead Sponsor: Dr A Kaffes

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-12-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Booking for colonoscopy.
Intact colon (no previous colonic resection).

Exclusion Criteria

Emergency colonoscopic procedure
Previous colon resection
Already included in this study
Glaucoma
Achalasia
Previous urinary retention
Known bowel obstructions
Myasthenia gravis
Porphyria
Fructose intolerance
Megacolon

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of colonic polyps detected by inspection of the bowel via a fibreoptic colonoscope in patients with polyps detected at the isolated single procedure of colonoscopy.[At the time of colonoscopy.]

Secondary Outcome Measures

Name	Time	Method
umber of patients with polyps detected by inspection of the bowel with a fibreoptic colonoscope during the isolated single procedure of colonoscopy.[At the time of colonoscopy];Average number of polyps detected by inspection of the bowel with a fibreoptic colonoscope during the isolated single procedure of colonoscopy.[At the time of colonoscopy.]